Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adaptive biotechnologies
alder biopharmaceuticals
alicrocumab
american academy of neu
american academy of neurology
amgen
bicycle therapeutics
biogen
biopharma
board of directors
What
head
2
×
america
amgen
approval
bio
biogen
candidates
class
continues
convoluted
democrats
developed
dreams
drug
fda
gets
headaches
healthcare
holding
insurance
ipo
medicines
migraine
moves
new
nod
pain
preventive
previews
private
public
roundup
scrutiny
spine
starts
suffer
week
won
Language
Current search:
head
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
